Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their physical abilities and quality of life. Medications known as cardiac ...
Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their physical abilities and quality of life. Medications known as cardiac ...
A repurposed drug reduced exertional desaturation and dyspnea by 62% and 27%, respectively, in patients with Covid-19 pulmonary sequelae, according to a recent Phase 3 study. In patients with ...
In idiopathic pulmonary fibrosis, 12 months of pulmonary rehabilitation increased cerebral oxygenation during exercise, ...
Respira Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing RT234 (vardenafil inhalation powder) as the first therapy that (PAH) patients can utilize on an as-needed ...
This encyclopedic article explains how prolonged inactivity affects cardiovascular, muscular, and connective tissue systems ...
Please provide your email address to receive an email when new articles are posted on . Exercise capacity and physical function improved in patients hospitalized for a COPD exacerbation with use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback